Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
Clinical trial NCT01681992 · COMPLETED
Trial details
- NCT number
- NCT01681992
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-10
- Primary completion
- 2015-02-03
- Enrollment
- 4538
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.